Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Seminars in Radiation Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.semradonc.2009.09.006PMID 19959029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• NCCN clinical practice guidelines in oncology: hepatobiliary cancers.

  2009cited by this paper
• Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.

  2009cited by this paper
• Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future.

  2009cited by this paper
• Survival after Hodgkin lymphoma

  2009cited by this paper
• Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

  2008cited by this paper
• Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients.

  2008cited by this paper
• The challenges of Hodgkin lymphoma in the elderly.

  2008cited by this paper
• A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis

  2008cited by this paper
• Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

  2008cited by this paper
• Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.

  2007cited by this paper
• Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans

  2007cited by this paper
• The ability of sorafenib to inhibit oncogenic PDGFRbeta and FLT3 mutants and overcome resistance to other small molecule inhibitors.

  2007cited by this paper
• Early, intermediate and advanced Hodgkin's lymphoma: modern treatment strategies.

  2007cited by this paper
• Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.

  2007cited by this paper
• Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

  2007cited by this paper
• Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease.

  2007cited by this paper
• Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

  2007cited by this paper
• Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma

  2007cited by this paper
• Hodgkin's lymphoma in the elderly: a different disease in patients over 60.

  2007cited by this paper
• Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.

  2007cited by this paper
• Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy

  2007cited by this paper
• Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.

  2007cited by this paper
• Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines.

  2006cited by this paper
• Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

  2006cited by this paper
• FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

  2006cited by this paper
• Long-term Events in Adult Patients with Clinical Stage IA-IIA Nonbulky Hodgkin's Lymphoma Treated with Four Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Adjuvant Radiotherapy: A Single-Institution 15-Year Follow-up

  2006cited by this paper
• Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

  2006cited by this paper
• Treatment-related premature ovarian failure as a long-term complication after Hodgkin's lymphoma.

  2006cited by this paper
• Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.

  2006cited by this paper
• Association of estrogen receptor-alpha genepolymorphisms with venous thrombosis.

  2006cited by this paper
• Epstein-Barr virus and Hodgkin's lymphoma.

  2006cited by this paper
• Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: A Pediatric Oncology Group (POG) study

  2006cited by this paper
• Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.

  2006cited by this paper
• Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia.

  2006cited by this paper
• The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

  2006cited by this paper
• Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.

  2005cited by this paper
• Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

  2005cited by this paper
• Fertility in males treated for Hodgkins disease with COPP/ABV hybrid

  2005cited by this paper
• Special issues in pediatric Hodgkin's disease

  2005cited by this paper
• A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

  2005cited by this paper
• Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.

  2005cited by this paper
• Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.

  2005cited by this paper
• Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?

  2005cited by this paper
• AIDS‐related lymphomas: from pathogenesis to pathology

  2005cited by this paper
• Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.

  2005cited by this paper
• Comparison of 30 Gy versus 20 Gy Involved Field Radiotherapy After Two Versus Four Cycles ABVD in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the German Hodgkin Study Group Trial HD10

  2005cited by this paper
• Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry.

  2005cited by this paper
• ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

  2005cited by this paper
• Special issues in pediatric Hodgkin's disease.

  2005cited by this paper
• First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)

  2005cited by this paper
• Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood hodgkin disease

  2004cited by this paper
• Familial aggregation of Hodgkin lymphoma and related tumors

  2004cited by this paper
• Age-Related Changes in the Ultrastructure of the Resting Follicle Pool in Human Ovaries1

  2004cited by this paper
• Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

  2004cited by this paper
• The German multinational GPOH-HD 95 trial: Treatment results and analysis of failures in pediatric Hodgkins disease using combination chemotherapy with and without radiation

  2004cited by this paper
• Pediatric Hodgkin's disease.

  2004cited by this paper
• Breast cancer risk and possible screening strategies for young women following supradiaphragmatic irradiation for Hodgkin's disease.

  2004cited by this paper
• ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.

  2004cited by this paper
• Childhood social environment and Hodgkin's lymphoma: new findings from a population-based case-control study.

  2004cited by this paper
• Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

  2004cited by this paper
• The HD12 Panel of the German Hodgkin Lymphoma Study Group (GHSG): A Quality Assurance Program Based on a Multidisciplinary Panel Reviewing All Patients’ Imaging

  2004cited by this paper
• Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.

  2003cited by this paper
• Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

  2003cited by this paper
• High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.

  2003cited by this paper
• Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.

  2003cited by this paper
• Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook.

  2003cited by this paper
• Long-term cause-specific mortality of patients treated for Hodgkin's disease.

  2003cited by this paper
• Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.

  2003cited by this paper
• Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

  2003cited by this paper
• Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.

  2003cited by this paper
• 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.

  2003cited by this paper
• Involved-field radiotherapy for advanced Hodgkin's lymphoma.

  2003cited by this paper
• Viruses and Hodgkin's lymphoma.

  2002cited by this paper
• ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.

  2002cited by this paper
• Screening for colorectal cancer: recommendation and rationale.

  2002cited by this paper
• VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.

  2002cited by this paper
• Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.

  2002cited by this paper
• Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review.

  2002cited by this paper
• Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.

  2002cited by this paper
• 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients

  2002cited by this paper
• The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer.

  2002cited by this paper
• The achievements of the EORTC Lymphoma Group

  2002cited by this paper
• Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

  2002cited by this paper
• Screening for Colorectal Cancer: Recommendation and Rationale

  2002cited by this paper
• Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

  2002cited by this paper
• Radiation and breast carcinogenesis.

  2001cited by this paper
• Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma

  2001cited by this paper
• 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

  2001cited by this paper
• Phase III randomized intergroup trial of subtotal lymphoid irradiation versus doxorubicin, vinblastine, and subtotal lymphoid irradiation for stage IA to IIA Hodgkin's disease.

  2001cited by this paper
• South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

  2001cited by this paper
• Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study.

  2000cited by this paper
• Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents

  2000cited by this paper
• Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.

  2000cited by this paper
• Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.

  2000cited by this paper
• Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.

  1999cited by this paper
• High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group.

  1999cited by this paper
• Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group.

  1998cited by this paper
• Epstein–Barr virus and Hodgkin’s disease: further evidence for the three disease hypothesis

  1998cited by this paper
• A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

  1998cited by this paper
• Birth order, sibship size and risk of Hodgkin's disease in children and young adults: A population‐based study of 31 million person‐years

  1997cited by this paper

• Retrospective Analysis of Prognostic Factors in Pediatric Hodgkin Lymphoma

  2026cites this paper
• Unfolding the enigma of familial Hodgkin lymphoma: Current insights

  2026cites this paper
• The national and subnational burden of Hodgkin Lymphoma (HL) in Italy from 1990 to 2023: results from the Global Burden of Disease Study 2023

  2025cites this paper
• Incidence and impact of prior history of serious infection in paediatric lymphoma: A population‐based study

  2025cites this paper
• Epstein-Barr virus (EBV) infection and its sequelae in the immunocompetent host.

  2025cites this paper
• A Retrospective Study on the Incidence, Mortality, and Risk Factors of Hodgkin Lymphoma in Pakistan

  2025cites this paper
• Body mass index and risk of Hodgkin's lymphoma: Insights from a Norwegian cohort study.

  2025cites this paper
• Pediatric Lymphomas: Key Concepts and Clinical Approaches for Pediatricians.

  2025cites this paper
• Targeted Therapies: The Role of Monoclonal Antibodies in Disease Management

  2025cites this paper
• Subverting the Canon: Novel Cancer-Promoting Functions and Mechanisms for snoRNAs

  2024cites this paper
• Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging

  2024cites this paper
• Incidence of hematologic cancer types in Japan by ICD-O-3 code: analysis of National Cancer Registry

  2024cites this paper
• Expression of mGluR5 in Pediatric Hodgkin and Non-Hodgkin lymphoma—A Comparative Analysis of Immunohistochemical and Clinical Findings Regarding the Association between Tumor and Paraneoplastic Neurological Disease

  2024cites this paper
• The impact of immunoarchitectural patterns on clinical presentation and response to therapy in children with nodular lymphocyte predominant Hodgkin lymphoma

  2024cites this paper
• Hodgkin's Lymphoma In Low-Income Countries: Experience Of Togo

  2024cites this paper
• Possibilities of radiotherapy in the treatment of pediatric Hodgkin lymphoma

  2024cites this paper
• Implementation of an Anterior Mediastinal Mass Pathway to Improve Time to Biopsy and Multidisciplinary Communication

  2024cites this paper
• Antibody–drug conjugates come of age in oncology

  2023cites this paper
• Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis

  2023cites this paper
• Proton Therapy in the Adolescent and Young Adult Population

  2023cites this paper
• Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma

  2023cites this paper
• Multimodality imaging workup of classical Hodgkin lymphoma in an 8-month-old child

  2023cites this paper
• Spectrum of Lymphoma: A Five Years’ Experience of Tertiary Care Centre in Eastern Nepal

  2022cites this paper
• Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.

  2022cites this paper
• Հոջկինի լիմֆոման մանկական տարիքում

  2022cites this paper
• Expression Profile of Selected Antitumor Immune Response Genes in Pediatric Classic Hodgkin Lymphoma

  2022cites this paper
• The ABVD’s of cooperative trials in pediatric Hodgkin lymphoma: The India experience

  2022cites this paper
• Letter to the Editor: Adult Atypical Hodgkin Lymphoma with Multiple Masses in the Liver and Spleen as the First Presentation.

  2022cites this paper
• Hispanic Ethnicity Differences in Birth Characteristics, Maternal Birth Place, and Risk of Early-Onset Hodgkin Lymphoma: A Population-Based Case-Control Study.

  2022cites this paper
• Çocukluk çağı hodgkin lenfomalarında CD163 ekspresyonunun prognostik önemi

  2022cites this paper
• A Case Report of Hodgkin's lymphoma with Early Manifestation of Henoch-Schonlein Purpura in a Child

  2022cites this paper
• Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis

  2022cites this paper
• What Lies Behind the Cannonball Pulmonary Metastases: Hodgkin's Lymphoma?

  2022influential citation
• Long-term residential exposure to air pollution and Hodgkin lymphoma risk among adults in Denmark: a population-based case–control study

  2021cites this paper
• Diagnostic Yield of PAX5 in Lymphoma

  2021cites this paper
• A Case of Recurrence/Refractory Mediastinal Hodgkin's Lymphoma Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation: Immunotherapy Brings Hope

  2021cites this paper
• Efficacies and Toxicities of Seven Chemotherapy Regimens for Advanced Hodgkin Lymphoma

  2021cites this paper
• The Impact of Complex Treatment, Doxorubicin C27H29NO11, Bleomycin C55H84N17O21S3, Vinblastine C46H58N4O9 and Dacarbazine C6H10N6O Correlated with Haematological Parameters on Hodgkin�s Lymphoma Survival Prognostic

  2020cites this paper
• Assessment of tumor Epstein-Barr Virus status and its impact on outcomes in intermediate and high-risk childhood classic Hodgkin Lymphoma treated at a tertiary cancer center in India

  2020cites this paper
• 85例儿童和青少年局限期霍奇金淋巴瘤临床分析

  2020cites this paper
• Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.

  2020cites this paper
• Treatment of childhood Hodgkin lymphoma in sub-Saharan Africa: A report from the French-African Paediatric Oncology Group (GFAOP)

  2020cites this paper
• Pediatric Hodgkin Lymphoma

  2020cites this paper
• The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes

  2020cites this paper
• Lymph nodes in the head and neck cancer: would diffusion-weighted magnetic resonance imaging solve the diagnostic dilemma?

  2020cites this paper
• Hepatic Manifestations of Lymphoproliferative Disorders.

  2019cites this paper
• DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin

  2019cites this paper
• Essentials of Hematology

  2019cites this paper
• Quality of life in survivors of adult haematological malignancy.

  2019cites this paper
• Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study

  2019cites this paper
• Outcomes in intermediate‐risk pediatric lymphocyte‐predominant Hodgkin lymphoma: A report from the Children's Oncology Group

  2018cites this paper
• Hodgkin’s Lynphoma Manifested With Bicytopenia Without Palpable Lymphadenomegaly

  2018cites this paper
• Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy

  2018cites this paper
• Thymic Tumors and Lymphomas: The Clinical Impact of Their Underlying Molecular Features

  2018cites this paper
• Unfavorable presentation but comparable outcome: Presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India

  2018cites this paper
• Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin’s lymphoma: influence on long-term adverse effects (SOPHIA)

  2018cites this paper
• Geographic Hematology: Some Observations in Mexico

  2018cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1411 Epidemiology and prognosis in classical Hodgkin lymphoma

  2017cites this paper
• Age and Sex in Non-Hodgkin Lymphoma Therapy: It's Not All Created Equal, or Is It?

  2017cites this paper
• International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia

  2017cites this paper
• Risk of Hodgkin lymphoma according to immigration status and origin: a migrant cohort study of 2.3 million Jewish Israelis

  2017cites this paper
• Differential prevalence and correlates of whole blood Epstein–Barr virus DNA between HIV-positive and HIV-negative men who have sex with men in Shanghai, China

  2017cites this paper
• Hematologic Diseases and Liver

  2016cites this paper
• Chapter 74 – Pediatric Hodgkin's Lymphoma

  2016cites this paper
• Incidence of Childhood Hodgkin Lymphoma in Mexico by Histologic Subtypes and Socioeconomic Regions

  2016cites this paper
• Pediatric Hodgkin Lymphoma.

  2015cites this paper
• An Unusual Massive Swelling of Neck Mimicking Parotid Tumor-A Case Report

  2015cites this paper
• Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature

  2015cites this paper
• Hodgkin Lymphoma in Childhood

  2015cites this paper
• Lymphomas and Lymphoproliferative Disorders

  2014cites this paper
• Hodgkin's lymphoma. An immunohistochemical profile in northern Iraq.

  2014cites this paper
• An immunohistochemical profile in northern Iraq

  2014cites this paper
• Hodgkin lymphoma – a survey of children and adolescents treated in Sweden 1985–2009

  2014cites this paper
• Lymphoma at King Hussein Medical Center: A Histopathologic Review

  2013cites this paper
• Hodgkin’s Lymphoma in adults at Chris Hani-Baragwanath Hospital: A fifteen year review

  2013cites this paper
• Resveratrol‐mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation

  2013cites this paper
• The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.

  2013cites this paper
• Blood malignancies in Mazandaran province of Iran.

  2013cites this paper
• Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

  2012cites this paper
• Mechanisms Linking Obesity and Leukemia Prognosis

  2012cites this paper
• Hodgkin and Non‐Hodgkin Lymphoma

  2012cites this paper
• Anesthetic management during labor and delivery: a 21-year review of women with cancer in a tertiary care center.

  2012cites this paper
• Anesthetic management during labor and delivery: a 21-year review of women with cancer in a

  2012cites this paper
• Epidemiology of Hematological Malignancies of Children, Adolescents, and Young Adults

  2012cites this paper
• Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents – a comprehensive review of biology, clinical course and treatment options

  2012cites this paper
• Hodgkin Lymphoma and Non-Hodgkin Lymphoma

  2012cites this paper
• Association between insurance and socioeconomic status and risk of advanced stage Hodgkin lymphoma in adolescents and young adults

  2012cites this paper
• Recent trend in risk assessment of formaldehyde exposures from indoor air

  2012influential citation
• Hodgkin's lymphoma in adults.

  2012cites this paper
• 192 – Hodgkin's Lymphoma

  2012cites this paper
• Clinical characteristics and prognostic factors in Chinese patients with Hodgkin’s lymphoma

  2012cites this paper
• Chapter 72 – Pediatric Hodgkin's Lymphoma

  2012cites this paper
• Hematologic and oncologic diseases and the liver.

  2011cites this paper
• Hodgkin's Lymphoma in Otorhinolaryngology

  2011cites this paper
• Leukemia and lymphoma.

  2011cites this paper
• [Hodgkin's lymphoma in otorhinolaryngology].

  2011cites this paper
• Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies

  2011cites this paper
• Increase in clusterin forms part of the stress response in Hodgkin's lymphoma.

  2011cites this paper
• Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran.

  2011cites this paper
• Differenzialdiagnose und Management der Lymphadenopathie im Kindes- und Jugendalter

  2010cites this paper